IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
Nature, Published online: 24 June 2020; doi:10.1038/s41586-020-2422-6
An engineered version of IL-18 that is resistant to binding by the soluble decoy receptor IL-18BP shows strong anti-tumour activity in mouse models of cancer.
Comments
Post a Comment